España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Tango Therapeutics
TNGX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.11
0.00
0.00%
At close: -
$3.10
-0.01000
-0.32%
After Hours: 5:15 PM EDT
Get Report
Comment
Tango Therapeutics (TNGX) Forecast
News
Earnings
Tango Therapeutics (TNGX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Tango Therapeutics (NASDAQ:TNGX) Stock
Tango Therapeutics Stock (NASDAQ: TNGX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, December 05, 2024
Unveiling 5 Analyst Insights On Tango Therapeutics
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Ta...
Benzinga Newsdesk
Wednesday, November 27, 2024
Tango Therapeutics Granted FDA Orphan Designa...
Benzinga Newsdesk
Monday, November 11, 2024
The Analyst Landscape: 5 Takes On Tango Therapeutics
Benzinga Insights
B. Riley Securities Maintains Buy on Tango Th...
Benzinga Newsdesk
Friday, November 08, 2024
HC Wainwright & Co. Reiterates Buy on Tango T...
Benzinga Newsdesk
Thursday, November 07, 2024
Guggenheim Maintains Buy on Tango Therapeutic...
Benzinga Newsdesk
Wednesday, November 06, 2024
Tango Therapeutics shares are trading lower a...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Tango Therapeutics Announced An Update On Its...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Monday, October 28, 2024
HC Wainwright & Co. Reiterates Buy on Tango T...
Benzinga Newsdesk
Thursday, October 10, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Tuesday, September 10, 2024
Analyst Scoreboard: 4 Ratings For Tango Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Tango T...
Benzinga Newsdesk
Thursday, August 08, 2024
Analyst Expectations For Tango Therapeutics's Future
Benzinga Insights
Wedbush Maintains Outperform on Tango Therape...
Benzinga Newsdesk
Wednesday, August 07, 2024
Tango Therapeutics shares are trading higher ...
Benzinga Newsdesk
Tango Therapeutics' Cash Balance Of $322M As ...
Benzinga Newsdesk
Tango Therapeutics Q2 2024 GAAP EPS $(0.24) B...
Benzinga Newsdesk
Wednesday, July 17, 2024
Jefferies Initiates Coverage On Tango Therape...
Benzinga Newsdesk
Tuesday, July 09, 2024
Cantor Fitzgerald Reiterates Overweight on Ta...
Benzinga Newsdesk
Expert Outlook: Tango Therapeutics Through The Eyes Of 6 Analysts
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Tango T...
Benzinga Newsdesk
Wednesday, June 26, 2024
CORRECTION: Tectonic Therapeutic Ticker Is 'T...
Benzinga Newsdesk
Tuesday, May 28, 2024
HC Wainwright & Co. Maintains Buy on Tango Th...
Benzinga Newsdesk
Friday, May 24, 2024
Guggenheim Maintains Buy on Tango Therapeutic...
Benzinga Newsdesk
Forecasting The Future: 4 Analyst Projections For Tango Therapeutics
Benzinga Insights
Barclays Maintains Overweight on Tango Therap...
Benzinga Newsdesk
Thursday, May 23, 2024
Tango Therapeutics Shuts Early-Stage Cancer Study Due To Liver Toxicity
Vandana Singh
Wedbush Maintains Outperform on Tango Therape...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Tango Therapeutics shares are trading lower a...
Benzinga Newsdesk
Tango Therapeutics Reports Discontinuation Of...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Reiterates Buy on Tango T...
Benzinga Newsdesk
Wednesday, May 08, 2024
Tango Therapeutics' Cash Position Of $344M As...
Benzinga Newsdesk
Tango Therapeutics Q1 2024 GAAP EPS $(0.35) M...
Benzinga Newsdesk
Thursday, April 04, 2024
Cantor Fitzgerald Initiates Coverage On Tango...
Benzinga Newsdesk
Wednesday, March 20, 2024
HC Wainwright & Co. Maintains Buy on Tango Th...
Benzinga Newsdesk
Monday, March 18, 2024
Tango Therapeutics shares are trading lower a...
Benzinga Newsdesk
Recap: Tango Therapeutics Q4 Earnings
Benzinga Insights
Tango Therapeutics' Cash Position Of $337M As...
Benzinga Newsdesk
Tango Therapeutics Q4 GAAP EPS $(0.32) Misses...
Benzinga Newsdesk
Monday, February 12, 2024
Piper Sandler Initiates Coverage On Tango The...
Benzinga Newsdesk
Thursday, January 04, 2024
Medivir's Licensee, Tango Therapeutics Dosed ...
Benzinga Newsdesk
Wednesday, January 03, 2024
Tango Therapeutics Says First Patient Dosed I...
Benzinga Newsdesk
Friday, December 08, 2023
B. Riley Securities Initiates Coverage On Tan...
Benzinga Newsdesk
Wednesday, November 08, 2023
Tango Therapeutics: Q3 Earnings Insights
Benzinga Insights
Tango Therapeutics' Q3 Cash Position Of $360M...
Benzinga Newsdesk
Tango Therapeutics Q3 EPS $(0.23) Beats $(0.3...
Benzinga Newsdesk
Show More
